Cargando…

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts

BACKGROUND: Age has been reported as an independent prognostic factor for melanoma-specific survival (MSS). We tested the hypothesis that age impacts the host anti-tumor immune response, accounting for age-specific survival outcomes in three unique melanoma patient cohorts. METHODS: We queried the U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Sarah A., Han, Joseph, Darvishian, Farbod, Tchack, Jeremy, Han, Sung Won, Malecek, Karolina, Krogsgaard, Michelle, Osman, Iman, Zhong, Judy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070187/ https://www.ncbi.nlm.nih.gov/pubmed/27760559 http://dx.doi.org/10.1186/s12967-016-1026-2

Ejemplares similares

2081: Phenotypic characterization of the CD4+ T-cell response during anti-CTLA4 therapy with ipilimumab in melanoma patients
por: Sherani, Farha, et al.
Publicado: (2018)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors
por: Gulati, Nicholas, et al.
Publicado: (2021)

Retroviral Transduction of T-cell Receptors in Mouse T-cells
por: Zhong, Shi, et al.
Publicado: (2010)

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis
por: Weiss, Sarah, et al.
Publicado: (2015)

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
por: Gowen, Michael F., et al.
Publicado: (2018)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
por: Lattanzi, Michael, et al.
Publicado: (2018)

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma
por: Chou, Margaret, et al.
Publicado: (2020)

Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011)

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
por: Johannet, Paul, et al.
Publicado: (2022)

Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients
por: Rosenbaum, Brooke E., et al.
Publicado: (2017)

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma
por: Yancovitz, Molly, et al.
Publicado: (2012)

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Specific increase in T cell potency via structure-based design of a T cell receptor for adoptive immunotherapy
por: Malecek, Karolina, et al.
Publicado: (2014)

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients
por: Yu, Jessie Z, et al.
Publicado: (2008)

Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo
por: O’Reilly, Kathryn E., et al.
Publicado: (2013)

Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013)

The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis
por: Moubarak, Rana S., et al.
Publicado: (2022)

FBXW7 modulates cellular stress response and metastatic potential via HSF1 post-translational modification
por: Kourtis, Nikos, et al.
Publicado: (2015)

Heterogeneity in Host Risk Factors for Incident Melanoma and Non-Melanoma Skin Cancer in a Cohort of US Women
por: Qureshi, Abrar A., et al.
Publicado: (2011)

An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma
por: Davalos, Veronica, et al.
Publicado: (2023)

Angiosarcoma of the Breast Masquerading as Hemangioma: Exploring Clinical and Pathological Diagnostic Challenges
por: Frey, Jordan D, et al.
Publicado: (2015)

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients
por: Donnelly, Douglas, et al.
Publicado: (2019)

Tumor immunogenomic signatures improve a prognostic model of melanoma survival
por: Morales, Leah, et al.
Publicado: (2021)

Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival
por: Morales, Leah, et al.
Publicado: (2023)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2023)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Primary Cutaneous Atypical Spindle Cell Lipomatous Tumor
por: Tchack, Madeline S., et al.
Publicado: (2021)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2022)

1,25-Dihydroxyvitamin D(3) increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line
por: Wood, Richard J, et al.
Publicado: (2001)

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis
por: Kolla, Avani M., et al.
Publicado: (2021)

Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma
por: Han, Dale, et al.
Publicado: (2015)

The Consolidation of Implicit Sequence Memory in Obstructive Sleep Apnea
por: Csabi, Eszter, et al.
Publicado: (2014)

In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis
por: Gaziel-Sovran, Avital, et al.
Publicado: (2013)

Persistent organic pollutants and risk of cutaneous malignant melanoma among women
por: Darvishian, Maryam, et al.
Publicado: (2021)

Clinical significance of BRAF mutations in metastatic melanoma
por: Chang, David Z, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_nrf4n3gm613jctb9bd431bc3r6